Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

Ballenger, J C; Burrows, G D; DuPont, R L; Lesser, I M; Noyes, R; Pecknold, J C; Rifkin, A; Swinson, R P

Ballenger, J C; Burrows, G D; DuPont, R L; Lesser, I M; Noyes, R; Pecknold, J C; Rifkin, A; Swinson, R P.

Affiliation

Ballenger JC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425.

Arch Gen Psychiatry ; 45(5): 413-22, 1988 May.

Article in En | MEDLINE | ID: mdl-3282478

Subject(s)

Alprazolam/therapeutic use; Anxiety Disorders/drug therapy; Fear; Panic; Adolescent; Adult; Aged; Anxiety Disorders/psychology; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anxiety Disorders / Panic / Alprazolam / Fear Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arch Gen Psychiatry Year: 1988 Type: Article

Search on Google

XML

PubMed Links